and many turn to diets, whether combined with medication, surgery or calorie restriction, to lose weight and improve overall health 1 , /PRNewswire/ -- Abbott (NYSE: ABT), a global leader in science-based nutrition, announced today the launch of its new PROTALITY brand
Sources: Davis SR, Castelo-Branco C, Chedraui P, et al
doi: 10.1038/nn1908 195 TranP
Rising Awareness and Access Issues Are Shaping Demand 47% of GLP-1 users are aware of the FDA's new policy shift that has restricted the availability of compounded semaglutide on the market, and 17% say it's been harder to get their medication because of it
As both diabetes diagnoses and the life expectancy of individuals with diabetes continue to rise, the total number of diabetic patients is expected to reach 629 million by 2045 [1], resulting in an increasing demand for anti-diabetes therapies